Daptomycin is a lipopeptide antibiotic produced by a nonribosomal peptide synthetase (NRPS) in Streptomyces roseosporus. The holoenzyme is composed of three subunits, encoded by the dptA, dptBC, and dptD genes, each responsible for incorporating particular amino acids into the peptide. We introduced expression plasmids carrying dptD or NRPS genes encoding subunits from two related lipopeptide biosynthetic pathways into a daptomycin nonproducing strain of S. roseosporus harboring a deletion of dptD. All constructs successfully complemented the deletion in trans, generating three peptide cores related to daptomycin. When these were coupled with incomplete methylation of 1 amino acid and natural variation in the lipid side chain, 18 lipopeptides were generated. Substantial amounts of nine of these compounds were readily obtained by fermentation, and all displayed antibacterial activity against gram-positive pathogens.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chembiol.2005.12.012 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The faucet knob effect of DptE crotonylation on the initial flow of daptomycin biosynthesis.
Metab Eng
January 2025
First Affiliated Hospital and Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China; Institute of Pharmaceutical Biotechnology, School of Medicine, Zhejiang University, Hangzhou, China. Electronic address:
Article Synopsis
- The study investigates how acylation, specifically crotonylation, regulates the production of daptomycin in the actinomycete Streptomyces roseosporus by modifying key metabolic enzymes.
- Researchers found that crotonylation of the enzyme DptE, which starts the daptomycin biosynthesis process, limits its activity and identified the enzymes involved in adding and removing the crotonyl group.
- By altering certain residues on DptE, the researchers enhanced its activity, significantly increasing daptomycin yield and suggesting potential improvements for industrial production through decrotonylation strategies.
Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin.
Microb Biotechnol
November 2024
State Key Laboratory of Animal Biotech Breeding and College of Biological Sciences, China Agricultural University, Beijing, China.
Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug-resistant Gram-positive pathogens, but the low yield hampers its large-scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high-yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S.
View Article and Find Full Text PDFLipidation Engineering in Daptomycin Biosynthesis.
J Am Chem Soc
November 2024
Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Republic of Korea.
Lipopeptides are an important family of natural products, some of which are clinically used as antibiotics to treat multidrug-resistant pathogens. Although the lipid moieties play a crucial role in balancing antibacterial activity and hemolytic toxicity, modifying the lipid moieties has been challenging due to the complexity of the lipidation process in lipopeptide biosynthesis. Here, we show that the lipid profile can be altered by engineering both secondary and primary metabolisms, using daptomycin as an example.
View Article and Find Full Text PDFRegulation of daptomycin biosynthesis in : new insights from genomic analysis and synthetic biology to accelerate lipopeptide discovery and commercial production.
Nat Prod Rep
December 2024
CognoGen Biotechnology Consulting, 7757 Uliva Way, Sarasota, FL 34238, USA.
Covering 2005-2024Daptomycin is a clinically important antibiotic that treats Gram-positive infections of skin and skin structure, bacteremia, and right-sided endocarditis, including those caused by methicillin-resistant (MRSA). Daptomycin is now generic, and many companies are involved in manufacturing and commercializing this life-saving medicine. There has been much recent interest in improving the daptomycin fermentation of by mutagenesis, metabolic engineering, and synthetic biology methods.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!